Ken Anderson Basic and Translational Research Award
Ken Anderson Basic and Translational Research Award
The Ken Anderson Basic and Translational Research Award was established by IMS to honor the seminal contributions of Professor Ken Anderson to bench to bedside translational research. This award is given to an investigator to recognize excellence in translational research in myeloma.
Recipient Profile
Nizar Bahlis is a Professor of Medicine at the University of Calgary in the division of Hematology and Bone Marrow Transplantation and a member of the Charbonneau Cancer Research Institute. Dr Bahlis received his medical degree in 1995 from St Joseph University – French Faculty of Medicine in Beirut. He then completed his internal Medicine residency at the State University of New York in Syracuse followed by a Hematology-Oncology fellowship at the University of Miami, Florida. Dr Bahlis also completed a postdoctoral fellowship in cancer biology at the University of Miami under the mentorship of Dr Lawrence Boise. Dr Bahlis’ clinical and laboratory research focus on the study of plasma cell dyscrasia, with particular interest in multiple myeloma genomics, single cell immune profiling, mechanisms of drug resistance and the development of novel therapeutics. He has received several awards and research funding from numerous agencies including the ASCO young investigator award, the Multiple Myeloma Research Foundation, The Leukemia and Lymphoma Society of Canada, Alberta Cancer Foundation, the National Institute of Health, the Terry Fox Foundations and the Canadian Institute of Health and Research (CIHR). His research work was published in many peer-reviewed journals including New England Journal of Medicine, Nature Medicine, Cancer Cell, Blood, Journal of Clininal Oncology, Blood Cancer Discovery, Leukemia, Molecular Cancer Research and Clinical Cancer Research. Dr Bahlis also served on the editorial board for the journal Blood and is an associate editor of the jounral Blood. He also serves on the review panel boards of several national and international funding agencies. He is a member of the American Society of Hematology (ASH), American Society of Clinical Oncology and served on the ASH plasma cell dyscrasia scientific panel.
Past Recipients
2017 – I. Ghobrial
2019 – C. Mitsiades
2021 – E. P. Neri
2022 – N. Raje
2023 – H. Avet-Loiseau
2024 – H. Einsele
2025 – P. L. Bergsagel
2026 – N. Bahlis
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
